The tariff classification of Sumatriptan Succinate (CAS-103628-48-4), Calcitonin (Salmon) (CAS-47931-85-1), and Amifostine (CAS-112901-68-5), imported in bulk form, from Spain, Belgium, and Poland, respectively
Issued October 24, 2003 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2935.00.6000, 2937.19.0000, 2930.90.9035
Product description
The first product, Sumatriptan Succinate, is indicated for the treatment of migraine. The second product, Calcitonin (Salmon), is a polypeptide hormone secreted by the ultimobranchial gland of fish. It is indicated for the treatment of Paget’s disease (of bone), hypercalcemia, and postmenopausal osteoporosis. The third product, Amifostine, is indicated to reduce renal toxicity associated with administration of cisplatin in patients with advanced ovarian cancer or non-small cell lung cancer. It is also indicated to reduce the incidence of moderate to severe xerostomia (dry mouth) in patients undergoing post-operative radiation treatment for head and neck cancer, where the irradiated area includes a substantial portion of the parotid glands.
CBP rationale
The applicable subheading for Sumatriptan Succinate, imported in bulk form, will be 2935.00.6000, Harmonized Tariff Schedule of the United States (HTS), which provides for “Sulfonamides: Other: Drugs: Other. The applicable subheading for Calcitonin (Salmon), imported in bulk form, will be 2937.19.0000, HTS, which provides for “Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: Other. The applicable subheading for Amifostine, imported in bulk form, will be 2930.90.9035, HTS, which provides for “Organo-sulfur compounds: Other: Other: Other: Other: Other: Other: Drugs.
Full text
NY J89898 October 24, 2003 CLA-2-29:RR:NC:2:238 J89898 CATEGORY: Classification TARIFF NO.: 2935.00.6000; 2937.19.0000; 2930.90.9035 Ms. Laura Mannisto Interchem Corporation 120 Route 17 North P.O. Box 1579 Paramus, NJ 07653-1579 RE: The tariff classification of Sumatriptan Succinate (CAS-103628-48-4), Calcitonin (Salmon) (CAS-47931-85-1), and Amifostine (CAS-112901-68-5), imported in bulk form, from Spain, Belgium, and Poland, respectively Dear Ms. Mannisto: In your letter dated October 10, 2003, you requested a tariff classification ruling. The first product, Sumatriptan Succinate, is indicated for the treatment of migraine. The second product, Calcitonin (Salmon), is a polypeptide hormone secreted by the ultimobranchial gland of fish. It is indicated for the treatment of Paget’s disease (of bone), hypercalcemia, and postmenopausal osteoporosis. The third product, Amifostine, is indicated to reduce renal toxicity associated with administration of cisplatin in patients with advanced ovarian cancer or non-small cell lung cancer. It is also indicated to reduce the incidence of moderate to severe xerostomia (dry mouth) in patients undergoing post-operative radiation treatment for head and neck cancer, where the irradiated area includes a substantial portion of the parotid glands. The applicable subheading for Sumatriptan Succinate, imported in bulk form, will be 2935.00.6000, Harmonized Tariff Schedule of the United States (HTS), which provides for “Sulfonamides: Other: Drugs: Other.” Pursuant to General Note 13, HTS, the rate of duty will be free. The applicable subheading for Calcitonin (Salmon), imported in bulk form, will be 2937.19.0000, HTS, which provides for “Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: Other.” The rate of duty will be free. The applicable subheading for Amifostine, imported in bulk form, will be 2930.90.9035, HTS, which provides for “Organo-sulfur compounds: Other: Other: Other: Other: Other: Other: Drugs.” Pursuant to General Note 13, HTS, the rate of duty will be free. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 301-443-1544. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Terlipressin Acetate (CAS No. 914453-96-6) in bulk powder form, from Spain
The tariff classification of Terlipressin (CAS No. 14636-12-5) in bulk power form, from Spain
The tariff classification of Glucagon (CAS No. 16941-32-5) in bulk powder form, from Spain
The tariff classification of Insulin Glargine (CAS No. 160337-95-1) in bulk form, from Germany
The tariff classification of Insulin Glulisine (CAS No. 207748-29-6) in bulk form, from Germany
The tariff classification of Semaglutide (CAS No. 910463-68-2) in bulk powder form, from Taiwan
The tariff classification of Tirzepatide (CAS No. 2023788-19-2) in bulk powder form, from Spain
The tariff classification of Semaglutide (CAS No. 910463-68-2) in bulk form, from Taiwan
The tariff classification of Setmelanotide Acetate (CAS No. 1504602-49-6) in bulk form, from Taiwan
The tariff classification of Ganirelix Acetate (CAS No. 129311-55-3) in bulk powder form, from Spain
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →